Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

887053

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential savings to be accrued to the public purse of the return of unused medicines to the NHS.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	136621
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The Department has made no assessment of the potential savings to be accrued to the public purse from the return of unused medicines to the National Health Service.</p><p> </p><p>The Department is concerned about wastage from unused medicines and is keen to minimise unnecessary extra costs. However, it does not promote the reuse of medicines that have left the pharmacy and been returned to a pharmacy by patients, as it is not possible to guarantee the quality of a returned medicine on physical inspection alone. When medicines are returned from patients’ homes, there is no way of knowing how the medicines have been stored or handled.</p><p> </p><p>The Royal Pharmaceutical Society publication, ‘Medicines Ethics and Practice - The professional guide for pharmacists (July 2017)’ states, “patients should be advised that unused, unwanted medicines should be returned to a pharmacy for safe disposal”</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:32:09 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

887073

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the Green Paper on Transforming children and young people’s mental health provision.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	136641
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>We plan to publish a Government response to the consultation on the Green Paper ahead of summer recess.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/04/2018 12:54:49 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1506 label Biography information for Andrew Gwynne

887120

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of ring-fencing part of the rebate paid by the pharmaceutical industry in the next iteration of the Pharmaceutical Price Regulation Scheme for the purposes of investing in NHS data infrastructure.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	136685
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>Under the current Pharmaceutical Price Regulation Scheme (PPRS) all payments go back into spending on improving patients’ health and care. Following normal Government accounting rules, there is no separately identified ring-fenced funding stream associated with the PPRS payment.</p><p> </p><p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:32:53 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

887197

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Speech and Language Therapy: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will ensure that every child and young person who stammers will be able to access speech and language therapy when needed; and if he will make a statement.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	136761
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The universal Healthy Child Programme includes a number of child development reviews at specific ages. The review at age 2 – 2½ is a crucial stage when problems such as speech and language delay or behavioural issues become visible and can be addressed by the health visitor before the child starts school.</p><p> </p><p>Clinical commissioning groups and local authorities have a legal duty to make joint arrangements for assessing the needs of children likely to have special educational needs.</p><p> </p><p>Since May 2016, Ofsted and the Care Quality Commission have been inspecting local areas on their effectiveness in fulfilling these new duties.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/04/2018 11:19:17 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4603 label Biography information for Preet Kaur Gill

887235

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ebola
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding was allocated to the Ebola contingency fund; and how much of that funding has been reallocated to other programmes.
tabling member constituency	Bradford East
tabling member printed	Imran Hussain
uin	136799
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>In 2018 the Department provided £4 million of Official Development Assistance funding to the World Health Emergencies Programme Contingency Fund which was set up in 2015 following the Ebola outbreak. The World Health Organization is responsible for the allocation of funds provided to the World Health Emergencies Programme Contingency Fund.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:34:37 answering member 4067 label Biography information for Steve Brine
tabling member	4394 label Biography information for Imran Hussain

887282

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to Office for National Statistics data on life expectancies, what assessment he has made of the reasons for the change in life expectancy at birth for females between 2009-11 and 2014-16 in (a) Uttesford, (b) Cheltenham, (c) Castle Point, (d) Purbeck, (e) East Staffordshire, and (f) Tendring.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	136846
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>Public Health England (PHE) is working with academic partners to produce a model to help determine underlying trends in life expectancy for all English local authorities. This model will take into account the revised population estimates recently issued by the Office for National Statistics. PHE expects to be able to report on the results of this analysis later in 2018.</p><p> </p><p>Care needs to be taken when analysing and interpreting local authority data as their small populations mean their life expectancy is subject to fluctuations from year to year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:33:46 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

887287

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many cases of (a) tuberculosis, (b) rickets and (c) measles were recorded in each month in the last 12 months.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	136851
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The data for cases of tuberculosis (TB) for the last 12 months are not available in the format requested.</p><p> </p><p>The most recent provisional data for the number and rate of TB cases notified in England in 2017 are available here:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/693328/TB_ad_hoc_statistics_March_2018.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/693328/TB_ad_hoc_statistics_March_2018.pdf</a></p><p>Data on the number of cases of rickets recorded in England for each of the last 12 months are not available in the format requested.</p><p> </p><p>The latest data available on the number of confirmed cases of rickets in England can be found here:</p><p><a href="https://digital.nhs.uk/data-and-information/find-data-and-publications/supplementary-information/2018-supplementary-information-files/count-of-finished-admission-episodes-faes-with-a-primary-or-secondary-diagnosis-of-scurvy-rickets-and-malnutrition-supplementary-information" target="_blank">https://digital.nhs.uk/data-and-information/find-data-and-publications/supplementary-information/2018-supplementary-information-files/count-of-finished-admission-episodes-faes-with-a-primary-or-secondary-diagnosis-of-scurvy-rickets-and-malnutrition-supplementary-information</a></p><p>Data on the number of cases of measles recorded in England for each of the last 12 months are not available in the format requested.</p><p> </p><p>The latest data available on the number of confirmed measles cases in England can be found here:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2017." target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2017.</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:30:00 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

887288

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure that the Medicines and Healthcare products Regulatory Agency will be supported to maintain its status as a world-leading regulator.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	136852
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is a strong national regulator with substantial capacity and expertise to regulate and evaluate the safety of our medicines and medical devices. The Agency is recognised globally for its expertise in licensing, inspections and batch release, and their pharmacovigilance regime is globally recognised and respected. Furthermore, the Agency is considered a leader within the European Union regulatory framework.</p><p> </p><p>The Government has been clear about our desire to negotiate a close relationship with the EU, including exploring with the EU the terms on which the United Kingdom could remain part of the European Medicines Agency. This was reinforced by my Rt. hon. Friend the Prime Minister in her Mansion House speech of 2 March. Nevertheless the MHRA will seek to become an even more influential partner internationally in its own right, and is committed to being a global leader, focusing on raising the quality of standards across the world.</p><p> </p><p>The Agency is also committed to continuing cooperation with international fora, including the International Medical Device Regulators Forum, the International Coalition of Medicines Regulatory Authorities and the International Council for Harmonisation of Technical Requirements for Human Use. The form that UK participation takes in some of these groups will depend on the outcome of the Future Economic Partnership negotiations with the EU.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/04/2018 13:34:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4036 label Biography information for Luciana Berger

887289

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Illness: Personal Health Budgets
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 January 2018 to Question 124498, on Mental Illness: Personal Health Budgets, how many people were in receipt of a personal health budget specifically to meet mental health needs in 2016-17.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	136853
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>In 2016/17 1,037 people had personal health budgets specifically to meet mental health needs.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/04/2018 11:20:54 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger

887291

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the effect of leaving the EU on early-phase clinical research.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	136855
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The Government has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation, including on early phase research and clinical trials. Every Government department, including the Department of Health and Social Care, is planning to deliver a smooth exit under any scenario, which includes preparing the UK for the future economic partnership we hope to negotiate with the European Union, as well as the very unlikely scenario in which no mutually satisfactory agreement can be reached and the UK exits without a deal.</p><p> </p><p>The UK is already a preferred destination for EU and global clinical trials – where much early phase research is concentrated. The Government has been clear that it is in the interest of patients and the Life Sciences industry across Europe for the UK and EU to find a way to continue cooperation in the field of clinical trials, and for continued sharing of data and information, even if our precise relationship with the EU will by necessity change. The Government is committing to being as aligned with the new EU Clinical Trials Regulation as we possibly can be, subject to the outcome of the future relationship negotiation.</p><p> </p><p>The National Institute for Health Research (NIHR) provides the support, expertise and facilities that the National Health Service needs to undertake world-leading early-phase research funded by the NIHR, and other public, charity and life sciences industry partners, by funding a range of infrastructure facilities. Through NIHR and its partners, and by close collaboration with the life sciences sector and industry, the Government will ensure that the UK remains one of the best places in the world for research, science and innovation.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/04/2018 11:23:03 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger